News
Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.
23h
MyChesCo on MSNArbutus Biopharma Showcases Promising Hepatitis B Research at EASL CongressArbutus Biopharma Corporation (Nasdaq: ABUS) announced the acceptance of five abstracts, including a late-breaking study, for ...
Functional cure, defined as durable hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) DNA titers below the ...
Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...
Abstracts are available on the EASL Congress 2025 website at https://www.easlcongress.eu/. The posters are expected to be ...
Compromised antigen presentation ranks among the top mechanisms that render cancers non-immunogenic (non-responsive to immune ...
The Food and Drug Administration (FDA) has granted Fast Track designation to PBGENE-HBV, an investigational gene editing therapy for adults with chronic hepatitis B.
Over the past years, China has achieved notable breakthroughs in vaccine technology. Milestones include the successful ...
According to WHO, 254 million people globally were estimated to have HBV in 2022, but only approximately 10% had been ...
Potential donors undergo standard screening tests conducted globally for lactating mothers, including tests for HIV, ...
Due to the overlapping reading frames in the HBV genome, RAMs in reverse transcriptase can also lead to changes in the overlapping surface antigen (HBsAg), potentially affecting vaccine efficacy.
An in-depth look at Hepatitis D, why it’s so severe, and how new therapies bring hope for better treatment and prevention.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results